
Arthritis drug prompts remarkable hair regrowth in severe alopecia areata, study finds
Six-month study shows the arthritis drug upadacitinib (Rinvoq) can trigger dramatic hair regrowth in severe alopecia areata, with 45-55% of patients reaching 80% scalp coverage (more at higher doses) and notable eyebrow/eyelash restoration; the treatment is off-label for alopecia in the US as AbbVie seeks FDA approval, while the EU recently approved it.













